Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Adverse Event Reporting
Login
menu
Home
Active Ingredients
Ustekinumab
Ustekinumab
Medicine
Status
PIL
SPC
XPIL
Legal Category
Active Ingredient(s)
Company
STELARA 130 mg concentrate for solution for infusion
Updated
PIL
28/04/23
SPC
25/05/23
No
A
Ustekinumab
Janssen Sciences Ireland
Stelara 45 mg Solution for Injection
Updated
PIL
28/04/23
SPC
25/05/23
No
A
Ustekinumab
Janssen Sciences Ireland
Stelara 45 mg solution for injection in pre-filled syringe
Updated
PIL
28/04/23
SPC
25/05/23
No
A
Ustekinumab
Janssen Sciences Ireland
Stelara 90 mg solution for injection in pre-filled syringe
Updated
PIL
28/04/23
SPC
25/05/23
No
A
Ustekinumab
Janssen Sciences Ireland
Direct Healthcare Professional Communications
Documents associated with this medicine were updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
